feature image

Institutional Biosafety Committee

The Institutional Biosafety Committee is responsible for monitoring and ensuring compliance as well as review and approval of all research projects that involve recombinant or synthetic nucleic acid molecules, including human gene transfer (clinical trials) in accordance with the NIH Guidelines.


The IBC Training module will soon transition to CITINews Flash

CITI = Collaborative Institutional Training Initiative 

This transition will NOT impact currently registered MyIBC Users, but will be required for new MyIBC Users who have not yet completed the NIH Guidelines training.  Do you have questions or concerns?  Contact the IBC Office staff!


Get to know your IBC Office Staff!

The IBC Office was established in the Spring of 2001, to assist the committee perform review functions, and to help researchers and their staff to achieve compliance with the NIH Guidelines

IBC Office staff are happy to assist individuals or groups to help work through the application process. 

Contact a staff member today! Call 412-383-1768 or send us an email at: ibo@pitt.edu

Research Guidance Tool>>

page updated 17 November 2016